New Draft FDA Guidance on ADC Pharmacology
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical pharmacology
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical pharmacology
Predictive, Diagnostic, and Pharmacodynamic Biomarkers Tobacco products kill more than five million people each year. Up to half of regular tobacco users eventually die of
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the majority
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest canopies.
Although large molecule drug discovery has become more popular recently, small molecules have always acted as the basis for the majority of drug research and
Until recently, many scientists were convinced that animal welfare and high-quality animal research were not compatible. Animal welfare was considered a nuisance that should be
While the wave of small molecule drug therapies going off patent has peaked, there are still a number that will be losing patent protection over
About a century ago, Otto Loewi discovered in his laboratories in Graz, Austria, that nerve impulses are transmitted by chemical messengers like acetylcholine. Since then,
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be applied
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues to
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs, being
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new drug
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical pharmacology
Predictive, Diagnostic, and Pharmacodynamic Biomarkers Tobacco products kill more than five million people each year. Up to half of regular tobacco users eventually die of
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the majority
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest canopies.
Although large molecule drug discovery has become more popular recently, small molecules have always acted as the basis for the majority of drug research and
Until recently, many scientists were convinced that animal welfare and high-quality animal research were not compatible. Animal welfare was considered a nuisance that should be
While the wave of small molecule drug therapies going off patent has peaked, there are still a number that will be losing patent protection over
About a century ago, Otto Loewi discovered in his laboratories in Graz, Austria, that nerve impulses are transmitted by chemical messengers like acetylcholine. Since then,
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be applied
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues to
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs, being
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new drug
Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711
"*" indicates required fields
Emails are serviced by Constant Contact. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.